Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis
Authors:
- 1 July 1995
- journal article
- case report
- Published by Springer Nature in Clinical Rheumatology
- Vol. 14 (4) , 481-484
Abstract
Idiopathic retroperitoneal fibrosis (RPF) is characterized by the development of a fibrotic mass surrounding the abdominal aorta and its branches, of unknown aetiology. Several immunlogical mechanisms can be operative in the pathogenesis of RPF. Based on this assumption we treated a patient affected by idiopathic RPF with low-dose methotrexate (MTX) therapy. To our knowledge this is the first example of the effectiveness and safety of a long-term low-dose MTX treatment in the post-surgical management of RPF.Keywords
This publication has 19 references indexed in Scilit:
- Retroperitoneal fibrosis.American Journal of Roentgenology, 1991
- Characterisation of Inflammatory Cells Associated with “Idiopathic Retroperitoneal Fibrosis”British Journal of Urology, 1991
- Retroperitoneal fibrosisUrologic Radiology, 1990
- Idiopathic Retroperitoneal Fibrosis – An UpdateDigestive Diseases, 1990
- The effects of methotrexate on the production and activity of interleukin‐1Arthritis & Rheumatism, 1989
- Antiproliferative effects of methotrexate on peripheral blood mononuclear cellsArthritis & Rheumatism, 1989
- Idiopathic Retroperitoneal Fibrosis. A Retrospective Analysis of 60 CasesBritish Journal of Urology, 1987
- Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosisArchives of internal medicine (1960), 1985
- AzathioprineArchives of internal medicine (1960), 1985
- The combined surgical and medical treatment of retroperitoneal fibrosisBritish Journal of Surgery, 1971